vs
Amplitude, Inc.（AMPL）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
Amplitude, Inc.的季度营收约是Cytek Biosciences, Inc.的1.5倍（$91.4M vs $62.1M），Amplitude, Inc.净利率更高（-19.3% vs -70.9%，领先51.6%），Amplitude, Inc.同比增速更快（17.0% vs 8.1%），Amplitude, Inc.自由现金流更多（$12.7M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 12.2%）
Amplitude是一家美国企业，专注于研发数字分析软件，能够帮助企业梳理用户行为数据、优化产品决策与数字化运营体验。该公司于2021年9月28日在纳斯达克交易所挂牌上市，股票代码为AMPL。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
AMPL vs CTKB — 直观对比
营收规模更大
AMPL
是对方的1.5倍
$62.1M
营收增速更快
AMPL
高出8.9%
8.1%
净利率更高
AMPL
高出51.6%
-70.9%
自由现金流更多
AMPL
多$14.4M
$-1.8M
两年增速更快
CTKB
近两年复合增速
12.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.4M | $62.1M |
| 净利润 | $-17.7M | $-44.1M |
| 毛利率 | 74.6% | 52.9% |
| 营业利润率 | -18.3% | -9.0% |
| 净利率 | -19.3% | -70.9% |
| 营收同比 | 17.0% | 8.1% |
| 净利润同比 | 45.8% | -557.1% |
| 每股收益（稀释后） | $-0.13 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPLCTKB
| Q4 25 | $91.4M | $62.1M | ||
| Q3 25 | $88.6M | $52.3M | ||
| Q2 25 | $83.3M | $45.6M | ||
| Q1 25 | $80.0M | $41.5M | ||
| Q4 24 | $78.1M | $57.5M | ||
| Q3 24 | $75.2M | $51.5M | ||
| Q2 24 | $73.3M | $46.6M | ||
| Q1 24 | $72.6M | $44.9M |
净利润AMPLCTKB
| Q4 25 | $-17.7M | $-44.1M | ||
| Q3 25 | $-24.0M | $-5.5M | ||
| Q2 25 | $-24.7M | $-5.6M | ||
| Q1 25 | $-22.2M | $-11.4M | ||
| Q4 24 | $-32.6M | $9.6M | ||
| Q3 24 | $-16.9M | $941.0K | ||
| Q2 24 | $-23.4M | $-10.4M | ||
| Q1 24 | $-21.5M | $-6.2M |
毛利率AMPLCTKB
| Q4 25 | 74.6% | 52.9% | ||
| Q3 25 | 73.9% | 52.7% | ||
| Q2 25 | 72.6% | 52.3% | ||
| Q1 25 | 74.7% | 48.6% | ||
| Q4 24 | 74.7% | 58.5% | ||
| Q3 24 | 75.1% | 56.3% | ||
| Q2 24 | 73.4% | 54.6% | ||
| Q1 24 | 74.0% | 51.3% |
营业利润率AMPLCTKB
| Q4 25 | -18.3% | -9.0% | ||
| Q3 25 | -26.0% | -17.6% | ||
| Q2 25 | -29.0% | -23.3% | ||
| Q1 25 | -26.8% | -36.1% | ||
| Q4 24 | -41.2% | 5.2% | ||
| Q3 24 | -21.4% | -8.2% | ||
| Q2 24 | -31.7% | -18.3% | ||
| Q1 24 | -29.0% | -23.9% |
净利率AMPLCTKB
| Q4 25 | -19.3% | -70.9% | ||
| Q3 25 | -27.1% | -10.5% | ||
| Q2 25 | -29.6% | -12.2% | ||
| Q1 25 | -27.8% | -27.5% | ||
| Q4 24 | -41.7% | 16.8% | ||
| Q3 24 | -22.4% | 1.8% | ||
| Q2 24 | -31.9% | -22.4% | ||
| Q1 24 | -29.5% | -13.8% |
每股收益（稀释后）AMPLCTKB
| Q4 25 | $-0.13 | — | ||
| Q3 25 | $-0.18 | — | ||
| Q2 25 | $-0.19 | — | ||
| Q1 25 | $-0.17 | — | ||
| Q4 24 | $-0.25 | — | ||
| Q3 24 | $-0.14 | — | ||
| Q2 24 | $-0.19 | — | ||
| Q1 24 | $-0.18 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $192.0M | $90.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.3M | $341.7M |
| 总资产 | $420.7M | $461.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMPLCTKB
| Q4 25 | $192.0M | $90.9M | ||
| Q3 25 | $189.2M | $93.3M | ||
| Q2 25 | $208.1M | $75.5M | ||
| Q1 25 | $209.0M | $95.3M | ||
| Q4 24 | $241.1M | $98.7M | ||
| Q3 24 | $319.9M | $162.3M | ||
| Q2 24 | $318.3M | $177.9M | ||
| Q1 24 | $316.1M | $168.8M |
股东权益AMPLCTKB
| Q4 25 | $245.3M | $341.7M | ||
| Q3 25 | $262.2M | $378.6M | ||
| Q2 25 | $279.5M | $377.6M | ||
| Q1 25 | $289.5M | $379.6M | ||
| Q4 24 | $296.6M | $395.7M | ||
| Q3 24 | $290.0M | $385.5M | ||
| Q2 24 | $287.3M | $389.1M | ||
| Q1 24 | $289.2M | $392.6M |
总资产AMPLCTKB
| Q4 25 | $420.7M | $461.5M | ||
| Q3 25 | $438.1M | $494.9M | ||
| Q2 25 | $456.6M | $493.3M | ||
| Q1 25 | $445.8M | $482.6M | ||
| Q4 24 | $445.9M | $499.5M | ||
| Q3 24 | $445.6M | $491.2M | ||
| Q2 24 | $445.4M | $483.7M | ||
| Q1 24 | $437.9M | $492.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.8M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | $12.7M | $-1.8M |
| 自由现金流率自由现金流/营收 | 13.8% | -2.9% |
| 资本支出强度资本支出/营收 | 0.2% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $28.2M | $-8.8M |
8季度趋势，按日历期对齐
经营现金流AMPLCTKB
| Q4 25 | $12.8M | $-771.0K | ||
| Q3 25 | $5.0M | $-3.9M | ||
| Q2 25 | $20.1M | $108.0K | ||
| Q1 25 | $-8.0M | $-125.0K | ||
| Q4 24 | $3.2M | $2.0M | ||
| Q3 24 | $6.2M | $13.2M | ||
| Q2 24 | $9.2M | $6.2M | ||
| Q1 24 | $-48.0K | $4.0M |
自由现金流AMPLCTKB
| Q4 25 | $12.7M | $-1.8M | ||
| Q3 25 | $4.5M | $-4.6M | ||
| Q2 25 | $19.5M | $-1.5M | ||
| Q1 25 | $-8.5M | $-974.0K | ||
| Q4 24 | $2.4M | $1.1M | ||
| Q3 24 | $6.2M | $12.2M | ||
| Q2 24 | $8.6M | $5.2M | ||
| Q1 24 | $-405.0K | $3.4M |
自由现金流率AMPLCTKB
| Q4 25 | 13.8% | -2.9% | ||
| Q3 25 | 5.1% | -8.7% | ||
| Q2 25 | 23.4% | -3.2% | ||
| Q1 25 | -10.6% | -2.3% | ||
| Q4 24 | 3.1% | 1.9% | ||
| Q3 24 | 8.2% | 23.7% | ||
| Q2 24 | 11.8% | 11.0% | ||
| Q1 24 | -0.6% | 7.6% |
资本支出强度AMPLCTKB
| Q4 25 | 0.2% | 1.6% | ||
| Q3 25 | 0.5% | 1.3% | ||
| Q2 25 | 0.6% | 3.5% | ||
| Q1 25 | 0.5% | 2.0% | ||
| Q4 24 | 1.0% | 1.6% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.8% | 2.3% | ||
| Q1 24 | 0.5% | 1.3% |
现金转化率AMPLCTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPL
| US | $55.8M | 61% |
| International | $35.7M | 39% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
